🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

228 notícias encontradas para "treatment"
Foto: Anna Tarazevich / Pexels
Novel technology could aid targeted lung cancer treatment
Scientists have developed a new method for accurately predicting gene changes that cause lung cancer, without the need for slower, more expensive lab techniques. The technology was able to identify specific genetic changes with high accuracy, offering a potentially faster, more e
Foto: Shubham Dhage / Pexels
Can cosmetic procedures become addictive? Study links addiction risk to social media and b
As cosmetic procedures surge worldwide and beauty content increasingly dominates social media platforms, a new study from the Hebrew University of Jerusalem suggests that for some women, cosmetic treatments may begin to resemble compulsive or addiction-like behavior. The study, l
Why the fastest-growing Ebola outbreak in history is becoming more challenging
The Ebola outbreak in eastern Congo is now the fastest-growing one in history, and new challenges keep emerging even as work begins on a study of two badly needed treatments for a type of Ebola that currently has none.
Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop
Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop
Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential treatment strategy that combines popular weight-lo
A natural compound steps into the estrogen arena
Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age. Existing treatments—hormonal drugs and selective estrogen receptor modulators—have side effects and cannot reliably prevent recurrence. This is w
Foto: Alesia  Kozik / Pexels
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial fi
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.
Raman imaging applied to cardiac tissue of Fabry disease model reveals molecular map of li
How are disease-relevant molecules distributed within tissue? What changes occur even before they become visible under the microscope? Questions such as these are crucial for early diagnosis and targeted treatment in many diseases. Researchers at the Leibniz-Institut für Analytis
Combination treatment harnesses cellular recycling system to fight multiple myeloma
New research from VCU Massey Comprehensive Cancer Center provides evidence for a combination treatment strategy that uses cells' waste-removal functions to target multiple myeloma. The findings, published recently in Cell Death & Disease, show how an experimental targeted protein
KRAS-targeting drugs show promise for rare appendix cancer
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.
Foto: Kampus Production / Pexels
Amyloid-clearing treatment may curb tau buildup for years in Alzheimer's brain
An analysis of the brain of a deceased Alzheimer's disease (AD) clinical trial participant found that regions where an anti-amyloid therapy successfully cleared amyloid plaques showed little to no evidence of tau tangles, a hallmark of AD closely linked to neurodegeneration and c
An experimental Alzheimer's drug shows promise targeting a different brain protein, new st
An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.
Foto: Artem Podrez / Pexels
Preclinical study points to a promising combined strategy for slowing the progression of t
An international research group led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined approach targeting both the immune system and insulin-producing beta cells can slow the progression of type 1 diabetes more effectively than individual treatment